Abstract

Cystic fibrosis is caused by more than 1000 mutations, the most common being the ΔF508 mutation. These mutations have been divided into five classes [1], with ΔF508 CFTR in class II. Here we have studied the class V mutation A455E. We report that the mature and immature bands of A455E are rapidly degraded primarily by proteasomes; the short protein half-life of this mutant therefore resembles that of ΔF508 CFTR. A455E could be rescued by treatment of the cells with proteasome inhibitors. Furthermore, co-transfection of A455E with the truncation mutant Δ264 CFTR also rescued the mature C band, indicating that A455E can be rescued by transcomplementation. We found that Δ264 CFTR bound to A455E, forming a bimolecular complex. Treatment with the compound correctors C3 and C4 also rescued A455E. These results are significant because they show that although ΔF508 belongs to a different class than A455E, it can be rescued by the same strategies, offering therapeutic promise to patients with Class V mutations.

Highlights

  • Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) [2]

  • Expression of A455E When we compared the expression of the A455E mutant to that of both wild-type and nF508 CFTR (Fig. 1) by western blotting, we found that the amount of CFTR protein was greatly reduced in the Cos7 cells transfected with the A455E mutant

  • Transcomplementation of nF508-CFTR by fragments of CFTR has been observed [13,14,17,20,20]. These fragments are themselves extremely efficiently degraded; they bind to DF508 CFTR and improve the maturation from the immature band B to mature band C

Read more

Summary

Introduction

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) [2]. Symptoms of CF include higher-than-normal sweat chloride, thick airway mucus, persistent lung infections, pancreatic enzyme insufficiency, intestinal blockage, and infertility in males [3]. Extensive effort has been made to understand the genotype of CF patients, with over 1000 gene mutations identified far [4] These mutations in the CF gene have been divided into five different classes: Class I mutations result in defective protein production. Class III mutations produce a protein that has defective regulation; the most common is the G551D mutation, which reaches the cell surface but does not conduct chloride [6,7]. Class V mutations affect protein synthesis or splicing, causing less protein to be made One of these class V mutations is A455E

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.